Yearly Archives: 2020

Labs@Home: Following the launch in April 2020 of Labs@Home in response to the COVID-19 pandemic began impacting transplant patient care and the world, Transplant Genomics, Inc. announced today the successful growth of TruGraf® driven by adoption of Labs@Home.

Sean Saint said, "I never really intended to start Companion Medical. After I was diagnosed with Type 1 in 2011, I started doing the research and realized that there were no other companies providing advanced technology and insulin intelligence to the millions of people with diabetes who decide not to be tethered to an insulin pump."

OrthogenRx notes the recently published response counters this position and addresses some recently reported economic and medical benefits not acknowledged within the AAOS CPGs.

"The New Era of Nicotine: Better for Patients?" released as part of the American Academy of Orthopaedic Surgeons' (AAOS) Virtual Education Experience found that smokers and non-smokers believe the use of e-cigarettes and other smoking alternatives have less of an impairment on bone fracture healing than smoking traditional cigarettes, when in fact the nicotine found in both cigarettes and e-cigarettes can impede the healing process.

With one of the world’s largest pharmaceutical companies, Oncimmune will further evaluate EarlyCDT Lung for the detection of lung cancer in at-risk patients. The initial phase of the collaboration will assess the utility of Early CDT Lung test at detecting incident lung cancer cases in a screening setting.